Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker ABBV
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Jeffrey R Stewart Officer | ABBV AbbVie Inc. | 40,619 | $11.9M | — | Nov 9, 2026 | Form 4 ↗ 3 days later · 40,619 shares | Form 144 ↗ |
| Aug 14, 2026 | Nicholas Donoghoe Officer | ABBV AbbVie Inc. | 32,710 | $8.2M | — | Aug 14, 2026 | Form 4 ↗ 4 days later · 32,710 shares | Form 144 ↗ |
| May 26, 2026 | Robert J Alpern Director | ABBV AbbVie Inc. | 13,000 | $2.8M | — | May 26, 2026 | — | Form 144 ↗ |
| Mar 6, 2026 | David R. Purdue Officer | ABBV AbbVie Inc. | 5,230 | $1.2M | — | Mar 4, 2026 | Form 4 ↗ same day · 5,230 shares | Form 144 ↗ |
| Mar 2, 2026 | Perry C Siatis Officer | ABBV AbbVie Inc. | 18,668 | $4.4M | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 1 day later · 18,668 shares | Form 144 ↗ |
| Feb 25, 2026 | Perry C Siatis Officer | ABBV AbbVie Inc. | 22,381 | $5.1M | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 2 days later · 22,381 shares | Form 144 ↗ |
| Aug 22, 2025 | Richard A. Gonzalez Former Director | ABBV AbbVie Inc. | 62,755 | $13.2M | — | Aug 22, 2025 | — | Form 144 ↗ |
| Aug 21, 2025 | Richard A. Gonzalez Former Director | ABBV AbbVie Inc. | 90,000 | $19.0M | — | Aug 21, 2025 | — | Form 144 ↗ |
| Aug 12, 2025 | Azita Saleki-Gerhardt Officer | ABBV AbbVie Inc. | 42,370 | $8.4M | — | Aug 12, 2025 | Form 4 ↗ 2 days later · 42,370 shares | Form 144 ↗ |
| Aug 8, 2025 | Richard A. Gonzalez Former Director | ABBV AbbVie Inc. | 91,600 | $19.2M | — | Aug 4, 2025 | — | Form 144 ↗ |
| Aug 8, 2025 | Richard A. Gonzalez Former Director | ABBV AbbVie Inc. | 35,120 | $6.8M | — | Aug 4, 2025 | — | Form 144 ↗ |
| Aug 8, 2025 | Richard A. Gonzalez Former Director | ABBV AbbVie Inc. | 61,500 | $12.0M | — | Aug 1, 2025 | — | Form 144 ↗ |
| Aug 5, 2025 | Nicholas Donoghoe Officer | ABBV AbbVie Inc. | 13,299 | $2.6M | — | Aug 5, 2025 | Form 4 ↗ 2 days later · 13,295 shares | Form 144 ↗ |
| Mar 31, 2025 | Stewart Jeffrey Ryan Officer | ABBV AbbVie Inc. | 58,832 | $12.4M | — | Mar 31, 2025 | Form 4 ↗ 2 days later · 58,832 shares | Form 144 ↗ |
| Mar 14, 2025 | Scott T. Reents Officer | ABBV AbbVie Inc. | 17,644 | $3.7M | — | Mar 14, 2025 | Form 4 ↗ 4 days later · 17,644 shares | Form 144 ↗ |
| Mar 3, 2025 | Richard A. Gonzalez Officer | ABBV AbbVie Inc. | 6,168 | $1.3M | — | Mar 3, 2025 | Form 4 ↗ 1 day later · 98,628 shares | Form 144 ↗ |
| Mar 3, 2025 | Perry C Siatis Officer | ABBV AbbVie Inc. | 18,008 | $3.8M | 10b5-1 | Mar 3, 2025 | Form 4 ↗ 1 day later · 27,900 shares | Form 144 ↗ |
| Mar 3, 2025 | Timothy Richmond Officer | ABBV AbbVie Inc. | 21,250 | $4.5M | 10b5-1 | Mar 3, 2025 | Form 4 ↗ 1 day later · 21,250 shares | Form 144 ↗ |
| Feb 28, 2025 | Richard A. Gonzalez Officer | ABBV AbbVie Inc. | 92,460 | $19.0M | — | Feb 28, 2025 | Form 4 ↗ 4 days later · 98,628 shares | Form 144 ↗ |
| Feb 28, 2025 | Perry C Siatis Officer | ABBV AbbVie Inc. | 9,892 | $2.0M | 10b5-1 | Feb 28, 2025 | Form 4 ↗ 4 days later · 27,900 shares | Form 144 ↗ |
| Feb 26, 2025 | Kevin K. Buckbee Officer | ABBV AbbVie Inc. | 18,944 | $3.9M | — | Feb 26, 2025 | Form 4 ↗ 2 days later · 18,944 shares | Form 144 ↗ |
| Feb 26, 2025 | Timothy Richmond Officer | ABBV AbbVie Inc. | 29,917 | $6.1M | 10b5-1 | Feb 26, 2025 | Form 4 ↗ 2 days later · 29,917 shares | Form 144 ↗ |
| Feb 20, 2025 | Perry C Siatis Officer | ABBV AbbVie Inc. | 5,778 | $1.1M | 10b5-1 | Feb 20, 2025 | Form 4 ↗ 4 days later · 5,778 shares | Form 144 ↗ |
| Dec 16, 2024 | Kevin K. Buckbee Officer | ABBV AbbVie Inc. | 1,800 | $310.0K | — | Dec 16, 2024 | Form 4 ↗ 2 days later · 1,800 shares | Form 144 ↗ |
| Aug 8, 2024 | Thomas J. Hudson Officer | ABBV AbbVie Inc. | 49,170 | $9.3M | — | Aug 8, 2024 | — | Form 144 ↗ |
| Aug 7, 2024 | Thomas J. Hudson Officer | ABBV AbbVie Inc. | 101,886 | $19.1M | — | Aug 7, 2024 | — | Form 144 ↗ |
| Aug 5, 2024 | Richard A. Gonzalez Officer | ABBV AbbVie Inc. | 66,500 | $12.5M | — | Aug 5, 2024 | — | Form 144 ↗ |
| Jul 17, 2024 | Richard Gonzalez Officer, Director | ABBV AbbVie Inc. | 282,845 | $49.5M | 10b5-1 | Jul 17, 2024 | — | Form 144 ↗ |
| Mar 21, 2024 amended | Nicholas Donoghoe Officer | ABBV AbbVie Inc. | 21,082 | $3.7M | — | Mar 20, 2024 | — | Form 144/A ↗ |
| Mar 20, 2024 | Nicholas Donoghoe Officer | ABBV AbbVie Inc. | 21,082 | $3.7M | — | Mar 20, 2024 | — | Form 144 ↗ |
| Mar 18, 2024 | Stewart Jeffrey Ryan Officer | ABBV AbbVie Inc. | 58,949 | $10.5M | — | Mar 18, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Scott T. Reents Officer | ABBV AbbVie Inc. | 14,140 | $2.5M | — | Feb 23, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Timothy Richmond Officer | ABBV AbbVie Inc. | 75,680 | $13.4M | 10b5-1 | Mar 1, 2024 | — | Form 144 ↗ |
| Feb 29, 2024 | Kevin K. Buckbee Officer | ABBV AbbVie Inc. | 5,145 | $908.7K | — | Feb 29, 2024 | — | Form 144 ↗ |
| Feb 29, 2024 | Robert A. Michael Officer | ABBV AbbVie Inc. | 68,879 | $12.2M | — | Feb 29, 2024 | — | Form 144 ↗ |
| Feb 29, 2024 | Perry C Siatis Officer | ABBV AbbVie Inc. | 9,911 | $1.8M | 10b5-1 | Feb 29, 2024 | — | Form 144 ↗ |
| Feb 28, 2024 | Richard A. Gonzalez Officer | ABBV AbbVie Inc. | 138,616 | $24.6M | — | Feb 28, 2024 | — | Form 144 ↗ |
| Feb 23, 2024 | Perry C Siatis Officer | ABBV AbbVie Inc. | 13,753 | $2.4M | 10b5-1 | Feb 23, 2024 | — | Form 144 ↗ |
| Feb 21, 2024 | Saleki-Gerhardt Azita Officer | ABBV AbbVie Inc. | 52,870 | $9.2M | — | Feb 21, 2024 | — | Form 144 ↗ |
| Feb 2, 2024 | Perry C Siatis Officer | ABBV AbbVie Inc. | 2,919 | $496.2K | 10b5-1 | Feb 2, 2024 | — | Form 144 ↗ |
| Dec 26, 2023 | Nicholas Donoghoe Officer | ABBV AbbVie Inc. | 2,912 | $450.6K | — | Dec 26, 2023 | — | Form 144 ↗ |
| Jul 31, 2023 | Richard A. Gonzalez Officer | ABBV AbbVie Inc. | 80,500 | $12.1M | — | Jul 31, 2023 | — | Form 144 ↗ |
| Jul 31, 2023 | Richard A. Gonzalez Officer | ABBV AbbVie Inc. | 80,500 | $12.1M | — | Jul 31, 2023 | — | Form 144 ↗ |
| Jul 25, 2023 | Elaine Sorg Officer | ABBV AbbVie Inc. | 8,191 | $1.2M | 10b5-1 | Jul 25, 2023 | — | Form 144 ↗ |
| Apr 25, 2023 | Elaine Sorg Officer | ABBV AbbVie Inc. | 6,130 | $1.0M | 10b5-1 | Apr 25, 2023 | — | Form 144 ↗ |
| Apr 17, 2023 | Elaine Sorg Officer | ABBV AbbVie Inc. | 7,499 | $1.2M | 10b5-1 | Apr 17, 2023 | — | Form 144 ↗ |
46 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances